Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1591)
Reports (55)
SAGE documentation (222)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (274)
Americas (766)
Eastern Mediterranean (50)
Europe (705)
South-East Asia (81)
Western Pacific (199)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (68)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (130)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (48)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4864 results found
2010
Statement on minimum information requirements to advertise the Genhevac B® vaccine against hepatitis b
2010
Statement on minimum information requirements to advertise the HBVax Pro® vaccine against hepatitis b
2010
Statement on minimum information requirements to advertise the Intanza® 15 mcg vaccine against seasonal influenza
2010
Statement on minimum information requirements to advertise the Varilrix® vaccine against varicella
2010
Statement on minimum information requirements to advertise the Varivax® vaccine against varicella
2010
Statement on the influenza vaccine strategy - season 2010-2011
2010
Statement on the influenza vaccine strategy in Reunion, season 2010
2010
Statement on the use of on the use of tetravalent meningococcal conjugate vaccine A, C, Y, W135 Menveo® - 25 June 2010
2010
Statement on vaccination against influenza via the Intanza® 15 mcg intradermal vaccine - 28 May 2010
2010
Statement on vaccination against influenza via the Intanza® 15 mcg intradermal vaccine - 29 October 2010
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
